Zoledronic Acid Oresund Pharma 5 mg/100 ml Norveġja - Norveġiż - Statens legemiddelverk

zoledronic acid oresund pharma 5 mg/100 ml

oresund pharma aps - zoledronsyremonohydrat - infusjonsvæske, oppløsning - 5 mg/100 ml

Zoledronic Acid Oresund Pharma 4 mg/100 ml Norveġja - Norveġiż - Statens legemiddelverk

zoledronic acid oresund pharma 4 mg/100 ml

oresund pharma aps - zoledronsyremonohydrat - infusjonsvæske, oppløsning - 4 mg/100 ml

Pantoprazol Oresund Pharma 40 mg Norveġja - Norveġiż - Statens legemiddelverk

pantoprazol oresund pharma 40 mg

oresund pharma aps - pantoprazolnatriumsesquihydrat - pulver til injeksjonsvæske, oppløsning - 40 mg

Ganciclovir Oresund Pharma 500 mg Norveġja - Norveġiż - Statens legemiddelverk

ganciclovir oresund pharma 500 mg

oresund pharma aps - ganciklovirnatrium - pulver til konsentrat til infusjonsvæske, oppløsning - 500 mg

Sutent Unjoni Ewropea - Norveġiż - EMA (European Medicines Agency)

sutent

pfizer limited - sunitinib - gastrointestinal stromal tumors; carcinoma, renal cell; neuroendocrine tumors - antineoplastiske midler - gastrointestinal stromal tumour (gist)sutent is indicated for the treatment of unresectable and/or metastatic malignant gastrointestinal stromal tumour (gist) in adults after failure of imatinib mesilate treatment due to resistance or intolerance. metastatic renal cell carcinoma (mrcc)sutent is indicated for the treatment of advanced/metastatic renal cell carcinoma (mrcc) in adults. pancreatic neuroendocrine tumours (pnet)sutent is indicated for the treatment of unresectable or metastatic, well-differentiated pancreatic neuroendocrine tumours with disease progression in adults. experience with sutent as first-line treatment is limited (see section 5.

Sunitinib Newbury 50 mg Norveġja - Norveġiż - Statens legemiddelverk

sunitinib newbury 50 mg

newbury pharmaceuticals ab - sunitinibmalat - kapsel, hard - 50 mg

Sunitinib Newbury 12.5 mg Norveġja - Norveġiż - Statens legemiddelverk

sunitinib newbury 12.5 mg

newbury pharmaceuticals ab - sunitinibmalat - kapsel, hard - 12.5 mg

Sunitinib Newbury 25 mg Norveġja - Norveġiż - Statens legemiddelverk

sunitinib newbury 25 mg

newbury pharmaceuticals ab - sunitinibmalat - kapsel, hard - 25 mg

Ilumetri Unjoni Ewropea - Norveġiż - EMA (European Medicines Agency)

ilumetri

almirall s.a - tildrakizumab - psoriasis - immunosuppressants, interleukin-hemmere, - ilumetri er indisert for behandling av voksne med moderat til alvorlig plakkpsoriasis som er kandidater for systemisk terapi.

RescueFlow 60 g/ L / 75 g/ L Norveġja - Norveġiż - Statens legemiddelverk

rescueflow 60 g/ l / 75 g/ l

oresund pharma aps - dekstran 70 / natriumklorid - infusjonsvæske, oppløsning - 60 g/ l / 75 g/ l